Date:05-May-2024  Time: 5:44 PM
 
 
        
Nectar Lifescience Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales452.16397.96394.12387.89
Other Income0.4810.610.4717.92
Total Income452.65408.57394.60406.74
Total Expenditure 409.98371.10358.58369.04
Operating Profit42.6737.4736.0137.70
Interest24.8420.5217.6219.66
Gross Profit17.8316.9518.3918.04
Depreciation15.3715.3115.3314.85
Tax0.000.000.000.00
Deferred Tax0.890.631.24-2.17
Reported Profit After Tax1.571.021.825.36
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com